Literature DB >> 2510116

The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas.

Charles Chabal1, Lisa C Russell, Kim J Burchiel.   

Abstract

The effects of intravenously administered subanesthetic concentrations of lidocaine, tocainide, and mexiletine on spontaneously active fibers (SAFs) originating in 7-day-old rat sciatic neuromas were studied. Control injections of normal saline caused no decrease in SAF or discharge rate. Lidocaine and tocainide given in incremental doses of 5, 10, 15, 20 and up to 25 mg/kg caused nearly all observed SAFs to stop firing. Mexiletine given in doses of 3, 5, 7, 10 and up to 15 mg/kg showed similar results at lower doses. All agents decreased the sensitivity of SAF to mechanical stimulation. No conduction blockade occurred at these doses of intravenously administered local anesthetics. The demonstrated reduction in firing rate of SAF may explain the pain relief observed in clinical trials of these orally available agents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510116     DOI: 10.1016/0304-3959(89)90220-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  25 in total

Review 1.  Sodium channels and pain.

Authors:  S G Waxman; S Dib-Hajj; T R Cummins; J A Black
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Intravenous lidocaine reduces ischemic pain in healthy volunteers.

Authors:  Michael A Frölich; Jason L McKeown; Mark J Worrell; Timothy J Ness
Journal:  Reg Anesth Pain Med       Date:  2010 May-Jun       Impact factor: 6.288

3.  Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury.

Authors:  T R Cummins; S G Waxman
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

4.  Current pharmacologic approaches to treating neuropathic pain.

Authors:  To-Nhu H Vu
Journal:  Curr Pain Headache Rep       Date:  2004-02

Review 5.  Drug infusions for the diagnosis and treatment of chronic pain.

Authors:  David A O'Gorman; Srinivasa N Raja
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 6.  Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions.

Authors:  S D Novakovic; E Tzoumaka; J G McGivern; M Haraguchi; L Sangameswaran; K R Gogas; R M Eglen; J C Hunter
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

Review 7.  Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia.

Authors:  M S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

8.  Lidocaine patch 5%.

Authors:  A M Comer; H M Lamb
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 9.  Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.

Authors:  Pamela S Davies; Bradley S Galer
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.

Authors:  B Jarvis; A J Coukell
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.